Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2400189	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products	Supplementary Application	2024-08-24		Takeda Pharmaceutical Co Ltd;Takeda Pharma A/S			view
JYSB2400177	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products(3.1)	Supplementary Application	2024-08-13		Takeda Pharmaceutical Co Ltd;Takeda Pharma A/S			view
JYSZ2400042	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products	License Renew	2024-07-06		Takeda Pharmaceutical Co Ltd;Takeda Pharma A/S			view
JYSB2300208	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products(3.1)	Supplementary Application	2023-12-09		Takeda Pharmaceutical Co Ltd;Takeda Pharma A/S			view
JXSL2200136	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products(2.2)	Import Drug Application	2022-08-18		Takeda Development Center Americas Inc			view
JXSL2200137	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products(2.2)	Import Drug Application	2022-08-18		Takeda Development Center Americas Inc			view
JYSB2200106	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products	Supplementary Application	2022-06-28		Takeda Pharmaceutical Co Ltd;Takeda Pharma A/S			view
JXSB2200007	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products(2.2)	Supplementary Application	2022-01-11		Takeda Pharmaceutical Co Ltd;Takeda Development Center Americas Inc			view
JXSB2200008	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products(2.2)	Supplementary Application	2022-01-11		Takeda Pharmaceutical Co Ltd;Takeda Development Center Americas Inc			view
JYSB2200001	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products	Supplementary Application	2022-01-05		Takeda Pharmaceutical Co Ltd;Takeda Pharma A/S			view
JXSL2101025	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products(2.2)	Import Drug Application	2021-05-14		Takeda Development Center Americas Inc			view
JXSL2101026	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products(2.2)	Import Drug Application	2021-05-12		Takeda Development Center Americas Inc			view
JYSB2101023	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products(3.1)	Supplementary Application	2021-05-10		Takeda Pharmaceutical Co Ltd;Takeda Pharma A/S			view
JYSB2000522	注射用维得利珠单抗	vedolizumab	Lyophilized	Biological Products	Supplementary Application	2020-10-19	武田药品（中国）有限公司	Takeda Pharmaceutical (China) Company LIMITED;Takeda Pharmaceutical Co Ltd;Takeda Pharma A/S	In Review	2020-10-16	view